Revealing the Impact of Genomic Alterations on Cancer Cell Signaling with an Interpretable Deep Learning Model

Jonathan D Young1, Shuangxia Ren1, Lujia Chen2

  • 1Intelligent Systems Program, School of Computing and Information, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Cancers
|August 12, 2023
PubMed

Insights

This study introduces a deep learning model, the redundant-input neural network (RINN), to understand how cancer-causing genomic alterations affect cellular signaling and gene expression. The RINN accurately predicts gene expression and reveals functional links between genomic alterations and signaling pathways.

Area of Science:

  • Computational biology
  • Genomics
  • Cancer research

Background:

  • Cancer arises from abnormal cellular signaling driven by somatic genomic alterations (SGAs).
  • Tumor heterogeneity leads to unique signaling system disruptions.
  • Understanding these complex signaling networks is crucial for cancer research.

Purpose of the Study:

  • To develop a computational model that interprets cancer signaling systems as causal graphical models.
  • To leverage deep learning to predict gene expression changes resulting from SGAs.
  • To identify shared functional impacts of SGAs on common signaling pathways.

Main Methods:

  • Developed a novel deep learning model named redundant-input neural network (RINN).
  • Utilized SGAs as direct inputs to the RINN model.
  • Employed causal graphical models to represent cancer signaling pathways.
  • Evaluated model performance using area under ROC curves for gene expression prediction.

Main Results:

  • The RINN model accurately predicts gene expression based on SGA inputs.
  • The model demonstrates the ability to encode the impact of SGAs on cellular signaling.
  • RINN successfully identifies shared functional impacts of SGAs affecting common pathways like PI3K, Nrf2, and TGF.
  • The model can rediscover known relationships within cellular signaling systems.

Conclusions:

  • The RINN model provides a transparent and effective tool for analyzing cancer signaling networks.
  • This approach enhances our understanding of how genomic alterations drive cancer progression.
  • The RINN model has the potential to uncover novel therapeutic targets by elucidating signaling pathway dysregulation.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
384